Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
78.2K
-
Shares change
-
-12.2K
-
Total reported value, excl. options
-
$330K
-
Value change
-
-$46.9K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$4.22
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q4 2023
3 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.2K shares
of 266M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (25M shares), FMR LLC (15.8M shares), CANADA PENSION PLAN INVESTMENT BOARD (10.2M shares), BAILLIE GIFFORD & CO (10.2M shares), VANGUARD GROUP INC (9.8M shares), BlackRock Inc. (8.47M shares), STATE STREET CORP (5.91M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.59M shares), Crestline Management, LP (3.37M shares), and Alphabet Inc. (2.81M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.